Learn the exact phrases that trigger FDA scrutiny when marketing Research Use Only products—and what to say instead.
Your antibody copy could land you an FDA warning letter. One wrong phrase on your website transforms a research tool into an unapproved diagnostic device in the eyes of regulators.
This conversation is for marketing managers at life science tools companies who need to promote Research Use Only (RUO) products without crossing regulatory lines. Josh Levin, former FDA compliance officer and diagnostics consultant, explains exactly which words trigger investigations and how to communicate analytical performance without implying diagnostic intent. Words matter: phrases like "used in diagnosis" or "detects disease" create regulatory risk; safer language references literature findings or analytical capabilities.
What you will learn:
Chapters:
Keywords: Research Use Only, RUO products, FDA compliance, life science marketing, diagnostic claims, regulatory copywriting, antibody marketing, lab developed tests, ISO 13485, clinical lab regulations, tools manufacturer compliance, FDA warning letters
Ready to ensure your marketing copy stays compliant? Watch this essential conversation, subscribe for more regulatory insights, and visit strivenn.com for expert guidance on life science marketing strategy.